N4 PHARMA PLC - Director's Dealing 2018

National Storage Mechanism | Additional information

RNS Number : 0925B

Evgen Pharma PLC

05 January 2018



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Evgen Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	change in percentage of voting rights arising upon a new issue of shares by the issuer			ü
3. Full name of person(s) subject to the notification obligation:		Enterprise Ventures Limited
4. Full name of shareholder(s) (if different from 3.):		RisingStars Growth Fund II LP
5. Date of the transaction and date on which the threshold is crossed or reached:		Total Voting Rights announcement of the issuer dated 2nd January 2018
6. Date on which issuer notified:		4th January 2017
7. Threshold(s) that is/are crossed or reached:		13%


8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction							Resulting situation after the triggering transaction
Number of Shares				Number of Voting Rights			Number of shares			Number of voting rights			% of voting rights
Direct			Direct	Indirect		Direct		Indirect
GB00BSVYN304	11,950,869				11,950,869			11,950,869			11,950,869	Nil		12.81		Nil

B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date			Exercise/ Conversion Period				Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
None

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date			Exercise/ Conversion period		Number of voting rights instrument refers to				% of voting rights
None													Nominal		Delta


Total (A+B+C)
Number of voting rights									Percentage of voting rights
11,950,869									12.81%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:


Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14. Contact name:	Enterprise Ventures Limited
15. Contact telephone number:	01772 270 570

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLGCGDBLSGBGIU

AI assistant